Raleigh Capital Management Inc. Bio Rad Laboratories, Inc. Transaction History
Raleigh Capital Management Inc.
- $255 Million
- Q3 2024
A detailed history of Raleigh Capital Management Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 12 shares of BIO stock, worth $4,474. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12
Previous 7
71.43%
Holding current value
$4,474
Previous $1,000
300.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BIO
# of Institutions
459Shares Held
20.5MCall Options Held
23.2KPut Options Held
37.4K-
Vanguard Group Inc Valley Forge, PA2.37MShares$885 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$578 Million0.01% of portfolio
-
Van Eck Associates Corp1.3MShares$486 Million0.55% of portfolio
-
Veritas Asset Management LLP1.09MShares$405 Million3.03% of portfolio
-
State Street Corp Boston, MA860KShares$321 Million0.01% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $9.19B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...